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Abstract Objective: To compare
the assessment of cardiac output
(CO) in children using the nonin-
vasive Ultrasound Cardiac Output
Monitor (USCOM) with the in-
vasive pulmonary artery catheter
(PAC) thermodilution cardiac output
measurement. Design and setting:
Prospective observational study in
a tertiary center for pediatric cardiol-
ogy of a university children’s hospital.
Patients: Twenty-four pediatric pa-
tients with congenital heart disease
without shunt undergoing cardiac
catheterization under general anes-
thesia. Measurements and results:
CO was measured by USCOM using
a suprasternal CO Doppler probe in
children undergoing cardiac catheter-
ization. USCOM data were compared
to CO simultaneously measured by
PAC thermodilution technique. Mea-
surements were repeated three times
within 5 min in each patient. A mean
percentage error not exceeding 30%
was defined as indicating clinical
useful reliability of the USCOM.
CO values measured by PAC
ranged from 1.3 to 5.3 l/min (me-
dian 3.6 l/min). Bias and precision
were –0.13 and 1.34 l/min, respec-
tively. The mean percentage error of
CO measurement by the USCOM
compared to PAC thermodilution
technique was 36.4% for USCOM.
Conclusions: Our preliminary data
demonstrate that cardiac output
measurement in children using the
USCOM does not reliably represent
absolute CO values as compared
to PAC thermodilution. Further
studies must evaluate the impact of
incorporating effective aortic valve
diameters on CO measurement using
the USCOM.
Keywords Cardiac output · Pul-
monary artery catheter · Monitoring ·
Hemodynamic · Children · Noninva-
sive
Introduction
In critically ill pediatric patients the measurement of car-
diac output (CO) is of considerable interest for the cardio-
vascular assessment and hemodynamic management [1].
In contrast to adult patients, in whom the thermodilution
method by pulmonary artery catheter (PAC) is widely ac-
cepted and used for CO measurement, this technique is not
routinely used in pediatric critical care due to its increased
risk of complications in children (infections, thrombosis,
embolism) and the size of the catheter, which is not con-
venient for continuous monitoring process in small chil-
dren [2].
The Ultrasound Cardiac Output Monitor (USCOM,
Sydney, Australia) is a noninvasive CO monitor based on
continuous-wave Doppler ultrasound (Fig. 1) for adults
and children. USCOM has been evaluated for dogs [3]
and for adult patients comparing it to CO thermodilution
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technique [4–7] and has been used in various clinical
settings [8–10]. No data are currently available with
regard to reliability of the USCOM for CO measurement
in children. The aim of this study was to compare CO
measurement by the noninvasive USCOM with the ther-
modilution technique during cardiac catheterization for
CO assessment in pediatric patients.
Materials and methods
Technique
After starting the USCOM device (Fig. 1) patient data, in-
cluding height, weight, and gender, are typed in as well as
the chosen vessel (aorta) is indicated. In children Doppler
flow curves by the USCOM are obtained by a 3.3-MHz
transducer placed in the suprasternal notch to obtain an
optimal aortic flow signal at the aortic valve. With contin-
uous slight movements of the USCOM probe the operator
aims to assess a clear systolic beginning and end, full sys-
tolic timing, and the highest velocities of the Doppler flow
curve. On the monitor display the Doppler curve is pre-
sented as a time velocity curve. A representative Doppler
curve is saved for further calculations. The CO value is
calculated using the flow integral, and the aortic valve di-
ameter as given by the USCOM internal algorithm based
on height and gender.
Patients
Hospital ethics committee approval and written parental
consent were obtained for all patients. Pediatric patients
with congenital heart disease undergoing diagnostic
and/or interventional cardiac catheterization under general
anesthesia were prospectively enrolled. Patients with
residual intracardiac or extracardiac shunt, tricuspid
or pulmonary valve regurgitation, body weight below
3 kg, and age older than 18 years were excluded. The
analysis included 24 patients aged 0.1–16.7 years (median
7.6) and weighing 3.4–51.0 kg (23.0 kg). Indications for
cardiac catheterization were device closure of an atrial
septal defect in nine and ventricular septal defect in six,
balloon dilatations of the pulmonary valve in two and
of branches of the pulmonary arteries in three, stenting
of a coarctation of the aortic arch in one, and for other
diagnostic reasons in three. Premedication and induction
of anesthesia (inhalational or intravenous) depended upon
the patient’s medical condition and anesthesiologist’s
preferences. After induction of general anesthesia and
after establishing neuromuscular blockade the patient was
intubated and ventilated by the anesthesia respirator. Prior
to the CO measurements we excluded a residual shunt
following device closure or a residual pulmonary valve
Fig. 1 Ultrasonic cardiac output monitor
regurgitation by transesophageal echocardiography and/or
angiography.
Cardiac output measurements
CO measurements were performed at the end of the
cardiac catheterization procedure under hemodynamic
steady-state conditions with the pulmonary artery ther-
modilution catheter and USCOM device in place. For ther-
modilution CO assessment a 5-F balloon-tipped pulmon-
ary artery catheter (Edwards Lifescience, Irvine, Calif.,
USA) was inserted via a 6-F sheath in the femoral vein
and directed to the pulmonary artery under fluoroscopic
control. CO was measured by PAC with 5-ml bolus injec-
tion of NaCl 0.9% at a temperature of 4°C, as described
elsewhere [2]. After a test injection three consecutive
measurements were performed. CO values for the US-
COM measurements were recorded immediately before
injection of each of the three repeated thermodilution
fluid boli. The USCOM measurement was performed
by a single experienced consultant pediatric cardiologist
after a learning curve prior the start of the study. The
cardiologist performing the USCOM measurement was
blinded to the CO measurements by the thermodilution
technique. A total of 72 paired CO measurements by
thermodilution and USCOM were recorded.
1062
Fig. 2 Bland–Altman analysis to compare cardiac output values ob-
tained by the USCOM and the thermodilution technique in 24 car-
diac pediatric patients
Statistics
Mean values of the three measurements for both methods
were calculated per patient and used for further statistics.
Intraobserver variability was calculated for the two meth-
ods. Bland–Altman analysis was performed to compare
CO values obtained by the USCOM with those obtained
by PAC thermodilution technique [11]. The mean propor-
tional error (2 SD/mean CO × 100) was calculated. Data
are presented as median (range). A mean percentage error
not exceeding 30% was defined as indicating clinical use-
ful reliability of the USCOM [12, 13].
Results
Mean CO values measured by PAC thermodilution tech-
nique ranged from 1.30 to 5.30 l/min (median 3.57) and
mean CO values measured by USCOM ranged from 0.86
to 5.93 l/min (4.04). Bias (mean difference) between the
two methods was –0.13 l/min and precision (± 2 SD of
differences) was 1.34 l/min (Fig. 2). The signal quality of
the USCOM Doppler was comparable and good in all pa-
tients independently of age. The intraobserver variability
was 3.1% by the PAC thermodilution technique and 5.7%
by USCOM measurement. The mean percentage error
of CO measurement was 36.4% for USCOM vs. to PAC
thermodilution technique.
Discussion
This study compared CO measurements between the new
noninvasive continuous-wave Doppler based monitoring
system USCOM and the thermodilution technique with
pulmonary artery catheter in pediatric patients with
congenital heart disease without shunts from infancy
to adolescence. The USCOM is a noninvasive cardiac
output monitor based on the transthoracic measurement
of Doppler flow velocity of the large intrathoracic vessels.
It is easy to operate, and CO is easily displayed by the
USCOM device. The technique is reported to be easily
learned even by noncardiologists and nursing staff [14].
The usefulness of fast and easy assessment of CO mon-
itoring by USCOM was supported by a previous study
by Knobloch et al. [8] in adult patients for hemodynamic
assessment in preclinical emergency medicine.
The main findings were that measurement of CO with
USCOM does not reliably represent absolute values as
compared to pulmonary artery catheter thermodilution
technique with a mean percentage error higher than 30%.
We believe that user dependency and technical factors
may contribute to this disagreement. User-dependent
factors must be taken into account such as the insonation
angle during measurement. Further technical factors of the
Doppler method are well known limitations, such as the
circumstance that the Doppler beam is one-dimensional
in a typical three-dimensional structure, and its flow is
considered laminar and described as plug flow, although it
is well known to be skewed.
Other patient-dependent factors such as implication of
the type of congenital heart defect in regard to the growth
of the aortic valve must be considered. The technique itself
may entail certain factors influencing the measurement.
One of these is the estimated aortic valve diameter. The
algorithm for the calculation of the aortic and pulmonary
valve diameter incorporated in the USCOM software is
based on the data of Nidorf et al. [15] and may involve
a systemic error during growth of the heart. These normal
values of cardiac dimensions published by Nidorf et al.
were evaluated for healthy children while in our study
children with congenital heart disease were examined,
which may contribute as a source of error. Further studies
could rule out this error by measuring the true aortic
valve diameter by transthoracic echocardiography and to
“calibrate” and adjust the USCOM measurement. The
impact of the direct measurement of the aortic valve
diameter to the measurement of the cardiac output by
conventional transthoracic Doppler echocardiography has
been shown [16].
In addition, the limitations of transthoracic pulsed
Doppler cardiac output measurement in comparison
to cardiac output measurement by the thermodilution
technique has been recognized [17]. On the other hand,
transesophageal continuous-wave Doppler cardiac output
measurement in comparison to the thermodilution tech-
nique seems to be suitable [18]. Therefore the Doppler
flow quality remains an important influencing factor.
Doppler flow signal quality may have been affected by
intrathoracic air, patient position, and operator’s learning
curve. In our study, however, the modalities of the USCOM
were optimal standardized (anesthesia, pediatric patients
with excellent access, and good sonographic window) so
that the impact of these factors may be rather low.
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Table 1 Summary of literature evaluating reliability of CO measurement by USCOM (d.n.a., data not available; LOA, limits of agreement;
calc., calculated)
Critchley et al. [3] Tan et al. [4] Chand et al. [5] Knobloch et al. [6] Chan et al. [7]
Setting Animal lab. model, Postcardiac surgery, Postcardiac surgery, Postcardiac surgery, Postcardiac surgery,
anesthetized dogs adult patients adult patients adult patients adult patients
Reference method Ultrasonic flow probe Thermodilution Thermodilution Thermodilution Thermodilution
Patients n = 6 n = 22, n = 50 n = 36 n = 26
mean age: 63.5 years mean age: 59.2 years mean age: 67.2 years mean age: 60.6 years
Simple regression d.n.a d.n.a d.n.a. R = 0.870, p < 0.01 R = 0.46, p < 0.01
Cardiac output: −0.01 l/min 0.18 l/min −0.14 l/min −0.23 l/min 0.22 l/min
bias (LOA) (−0.34 to 0.31) (−1.43 to 1.78) (−1.43 to 1.58) (−2.52 to 1.79) (−1.17 to 1.62)
Mean error 13% d.n.a. 34% (calc.) 42% (calc.) 54% (calc.)
To our knowledge, this is the first study in pediatric
patients validating CO measurement by USCOM with CO
measurement by PAC thermodilution considered as gold
standard (Table 1). USCOM has demonstrated reliable
results of CO measurements in laboratory animal studies
by using aortic flow probes in anesthetized dogs. The
investigators found 95% limits of agreement of –0.34 and
0.31 l/min over a wide range of cardiac output values [3].
Tan et al. [4] recently evaluated the USCOM vs. ther-
modilution cardiac output measurements in adult patients
after cardiac surgery and found, comparable to our results,
95% limits of agreement for the two techniques of –1.43
and 1.78 l/min. Chand et al. [5] and Chan et al. [7] con-
firmed this level of agreement of the two techniques in
a similar clinical setting with adult patients after cardiac
surgery. For both studies we calculated the mean percent-
age error, which exceeds 30% (Table 1). Although their
agreements were less than those obtained in our study, the
authors judged the USCOM to be a reliable technique for
CO assessment.
The fact that our study included no patients with nor-
mal cardiac anatomy included may be considered as limi-
tation of this study. However, cardiac catheterization with
the opportunity of PAC thermodilution CO assessment in
patients without heart disease is very rare, and limits this
type of investigation to pediatric patients with congenital
heart disease or critically ill pediatric patients on the inten-
sive care unit. In this study a single operator performed all
USCOM measurements. Further studies must investigate
interrater and intrarater reliability of the USCOM method.
Since the aortic valve diameter may be a crucial and un-
known factor in the calculation of absolute CO value, the
USCOM may become a trend monitor rather than a tool for
the assessment of absolute CO values. To support this ap-
plication of USCOM in pediatric patients further research
on long-term and repeated CO measurements is needed.
In the future, USCOM may rather serve as a feasible,
fast usable, valuable diagnostic tool to measure cardiac
output and to demonstrate therapeutic hemodynamic ef-
fects, for example, of fluid challenge and intropic supports
in critical ill children, by comparing pre- and postthera-
peutic CO values with USCOM. In this clinical settings
the absolute value of CO may be rather unimportant as the
fact the CO has increased from a “low” CO to a “normal”
or even “high” CO.
In conclusion, based on our findings USCOM cannot
be recommended for the assessment of absolute CO
values in pediatric cardiac patients. Further studies must
determine whether the incorporation of measured aortic
valve diameter can improve accuracy of the USCOM, and
whether the device can be reliably used as a trend monitor
for cardiac output assessment.
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